PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 1413: Targetable gene dependencies in Ewing sarcoma subtypes.

View Full Paper
DPDusan PesicJNJosh NashTWTimmy T. Wen

Key Points

  • This research aims to characterize the transcriptional subtypes of Ewing sarcoma and identify targetable gene dependencies for personalized therapies.
  • Used RACCOON clustering to classify Ewing sarcoma into distinct transcriptional subtypes
  • Analyzed single-cell resolution data and preclinical models to confirm subtype variability
  • Examined survival outcomes associated with different subtypes in clinical cohorts
  • Conducted in vivo experiments using patient-derived xenografts to assess metastatic potential
  • Performed CRISPR screenings to identify gene dependencies linked to specific subtypes
  • Identified three transcriptional subtypes: EWS::FLI1-high, mesenchymal-like, and muscle-like
  • Mesenchymal-like tumors exhibited the poorest prognosis with less than 35% five-year overall survival
  • In vivo studies showed mesenchymal-like tumors had significantly greater metastatic potential
  • The Fanconi anemia pathway was identified as a potential therapeutic target for EWS::FLI1-high tumors

Abstract

Abstract Ewing sarcoma (EwS) is a bone and soft tissue cancer primarily driven by a FET::ETS fusion protein, most commonly EWS::FLI1. While localized tumors have a five-year survival rate of 70-80% with multimodal treatment, the prognosis for relapsed or metastatic disease remains dismal, with survival rates below 30%. This underscores the urgent need for improved prognostic markers and innovative therapeutic strategies. Using an unsupervised hierarchical clustering approach - RACCOON - we identified three distinct transcriptional subtypes of EwS: EWS::FLI1-high, mesenchymal-like, and muscle-like. The muscle-like group, potentially arising from myofiber infiltration, formed a separate cluster, while the remainder of the cohort was distributed along a continuum of transcriptional states between the EWS::FLI1-high and EWS::FLI1-low/mesenchymal extremes. The same variability in these two transcriptional programs was observed at single-cell resolution and across commonly used preclinical EwS models. Subtype classification in clinical cohorts revealed significant survival differences, with mesenchymal-like tumors showing the poorest prognosis (35% five-year overall survival) and the highest metastatic potential. An in vivo experiment in patient-derived xenografts (PDXs) reinforced these findings, as mesenchymal-like tumors exhibited significantly greater metastatic potential. Additionally, functional genomics data from CRISPR-screened cell lines identified subtype-specific gene dependencies - the Fanconi anemia pathway emerged as a promising therapeutic target for EWS::FLI1-high tumors, while mesenchymal-like tumors showed reliance on distinct transcriptional regulators. By integrating transcriptomic profiling with functional genomics, this study highlights the biological and clinical heterogeneity of EwS, offering novel insights into its molecular underpinnings and paving the way for personalized treatment strategies tailored to specific transcriptional subtypes. Citation Format: Dusan Pesic, Josh Nash, Timmy Wen, Pedro Lemos Ballester, Livia Garzia, Olivier Delattre, David Malkin, Adam Shlien. Targetable gene dependencies in Ewing sarcoma subtypes abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1413.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pesic et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd13a79560c99a0a2eddhttps://doi.org/10.1158/1538-7445.am2026-1413
Ask AI
Helpful
Bookmark
Share
View Full Paper